These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28450532)

  • 21. MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation.
    Dastmalchi N; Safaralizadeh R; Hosseinpourfeizi MA; Baradaran B; Khojasteh SMB
    Mol Biol Rep; 2021 Feb; 48(2):1345-1357. PubMed ID: 33555529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-129-5p is downregulated in breast cancer cells partly due to promoter H3K27m3 modification and regulates epithelial-mesenchymal transition and multi-drug resistance.
    Luan QX; Zhang BG; Li XJ; Guo MY
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4257-4265. PubMed ID: 27831649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
    Sun FD; Wang PC; Luan RL; Zou SH; Du X
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-339-5p regulates the p53 tumor-suppressor pathway by targeting MDM2.
    Jansson MD; Damas ND; Lees M; Jacobsen A; Lund AH
    Oncogene; 2015 Apr; 34(15):1908-18. PubMed ID: 24882579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2.
    Zhang Y; Xia F; Zhang F; Cui Y; Wang Q; Liu H; Wu Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):26. PubMed ID: 30665445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR-200c-3p to upregulate ANLN.
    Zhang M; Wang F; Xiang Z; Huang T; Zhou WB
    Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1464-1472. PubMed ID: 32198770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
    Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298.
    Bao L; Hazari S; Mehra S; Kaushal D; Moroz K; Dash S
    Am J Pathol; 2012 Jun; 180(6):2490-503. PubMed ID: 22521303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-202-5p/
    Liu T; Guo J; Zhang X
    Cancer Biol Ther; 2019; 20(7):989-998. PubMed ID: 30983514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53.
    Zhou X; Sang M; Liu W; Gao W; Xing E; Lü W; Xu Y; Fan X; Jing S; Shan B
    Life Sci; 2012 Sep; 91(9-10):358-63. PubMed ID: 22906635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SNHG9/miR-214-5p/SOX4 feedback loop regulates osteosarcoma progression.
    Bai CJ; Gao T; Liu JY; Li S; Wang XY; Fan ZF
    Neoplasma; 2022 Sep; 69(5):1175-1184. PubMed ID: 36004648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
    Cheng J; Zhang R; Yan M; Li Y
    BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
    Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells.
    Yarahmadi S; Abdolvahabi Z; Hesari Z; Tavakoli-Yaraki M; Yousefi Z; Seiri P; Hosseinkhani S; Nourbakhsh M
    Gene; 2019 Aug; 711():143939. PubMed ID: 31220581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
    Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
    BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circular RNA circ_0011385 promotes cervical cancer progression through competitively binding to miR-149-5p and up-regulating SOX4 expression.
    Xu AL; Wang WS; Zhao MY; Sun JN; Chen XR; Hou JQ
    Kaohsiung J Med Sci; 2021 Dec; 37(12):1058-1068. PubMed ID: 34369654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR/PI3K signaling pathway.
    Huang Q; Wu YY; Xing SJ; Yu ZW
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5285-5292. PubMed ID: 31298380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
    Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
    Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.